Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve To consider and approve the Un-Audited (Standalone) Financial Results of the Company for the Quarter ended on 30th June, 2026.This is also to inform that the Trading Window of the Company has been closed from 01st July, 2026 and will remain closed till the completion of 48 hours after the declaration of unaudited (Standalone) Financial Results of the Company for the quarter ended on 30th June, 2026.2. Any other agenda, with prior permission of Chairperson.